Bone marrow regeneration promoted by biophysically sorted osteoprogenitors from mesenchymal stromal cells

Stem Cells Translational Medicine

Volumn 4, Issue 1, 2014, Pages 56-65

  Poon, Zhiyong ^a   Lee, Wong Cheng ^a,b   Guan, Guofeng ^a,b   Nyan, Linmyint ^a   Lim, Chwee Teck ^a,b,c   Han, Jongyoon ^a,d,e   Van Vliet, Krystyn J ^a,e  

^a SINGAPORE MIT ALLIANCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d Department of Electrical Engineering and Computer Science   (United States)

^e Massachusetts Institute of Technology   (United States)

Author keywords

Adult stem cells; Bone marrow; Mesenchymal stem cells; Tissue regeneration

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ANGIOPOIETIN 1; BONE MORPHOGENETIC PROTEIN 2; CD146 ANTIGEN; CD19 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; HERMES ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; NESTIN; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; THY 1 ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DISEASE; BONE MARROW INJURY; BONE MARROW REGENERATION; BONE MARROW STROMA CELL; CELL ISOLATION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STROMA CELL; MICROFLUIDIC ANALYSIS; NONHUMAN; OSTEOPROGENITOR CELL; PROTEIN EXPRESSION; TISSUE REGENERATION; TISSUE REPAIR; ANIMAL; BONE MARROW; BONE MARROW CELL; CELL SEPARATION; CYTOLOGY; HIGH THROUGHPUT SCREENING; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE;

MURINAE;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL SEPARATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MICROFLUIDIC ANALYTICAL TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84919815678     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0154     Document Type: Article

References (40)

1. Keating A. Mesenchymal stromal cells: New directions. Cell Stem Cell 2012;10:709–716.
2. Horwitz EM. MSC: A coming of age in regenerative medicine. Cytotherapy 2006;8:194–195.
3. Ranganath SH, Levy O, Inamdar MS et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012;10:244–258.
4. Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 2008;10:771–774.
5. Heo SC, Jeon ES, Lee IH et al. Tumor necrosis factor-a-activated human adipose tissuederived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms. J Invest Dermatol 2011;131: 1559–1567.
6. Yang X, Balakrishnan I, Torok-Storb B et al. Marrow stromal cell infusion rescues hematopoiesis in lethally irradiated mice despite rapid clearance after infusion. Adv Hematol 2012; 2012:142530.
7. Sorrell JM, Caplan AI. Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther 2010;1:30.
8. Bianco P, Riminucci M, Gronthos S et al. Bone marrow stromal stem cells: Nature, biology, and potential applications. STEM CELLS 2001;19:180–192.
9. Phinney DG. Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy. J Cell Biochem 2012;113:2806–2812.
10. Morad V, Pevsner-Fischer M, Barnees S et al. The myelopoietic supportive capacity of mesenchymal stromal cells is uncoupled from multipotency and is influenced by lineage determination and interference with glycosylation. STEM CELLS 2008;26:2275–2286.
11. Al-Nbaheen M, Vishnubalaji R, Ali D et al. Human stromal (mesenchymal) stem cells from bonemarrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev 2013;9:32–43.
12. Lee RH, Kim B, Choi I et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14: 311–324.
13. Ehninger A, Trumpp A. The bone marrow stem cell niche grows up: Mesenchymal stem cells and macrophages move in. J Exp Med 2011;208:421–428.
14. El-Badri NS, Wang BY, Cherry et al. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp Hematol 1998;26: 110–116.
15. Greenbaum A, Hsu YM, Day RB et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 2013;495:227–230.
16. Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013;495:231–235.
17. Kopp HG, Hooper AT, Avecilla ST et al. Functional heterogeneity of the bone marrow vascular niche. Ann N Y Acad Sci 2009;1176: 47–54.
18. Park D, Spencer JA, Koh BI et al. Endogenous bone marrow MSCs are dynamic, faterestricted participants in bone maintenance and regeneration. Cell Stem Cell 2012;10:259–272.
19. Cao X, Wu X, Frassica D et al. Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells. Proc Natl Acad Sci USA 2011;108:1609–1614.
20. Hooper AT, Butler JM, Nolan DJ et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009;4:263–274.
21. Shirota T, Tavassoli M. Cyclophosphamideinduced alterations of bone marrow endothelium: Implications in homing of marrow cells after transplantation. Exp Hematol 1991;19: 369–373.
22. Zeng L, Yan Z, Ding S et al. Endothelial injury, an intriguing effect of methotrexate and cyclophosphamide during hematopoietic stem cell transplantation in mice. Transplant Proc 2008;40:2670–2673.
23. Poncin G, Beaulieu A, Humblet C et al. Characterization of spontaneous bone marrow recovery after sublethal total body irradiation: Importance of the osteoblastic/adipocytic balance. PLoS ONE 2012;7:e30818.
24. Robey PG, Termine JD. Human bone cells in vitro. Calcif Tissue Int 1985;37:453–460.
25. Li Z, Liu C, Xie Z et al. Epigenetic dysregulation inmesenchymalstem cell agingand spontaneous differentiation. PLoS ONE 2011;6: e20526.
26. Boxall SA, Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012;2012:975871.
27. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells:Biologyof adultmesenchymal stem cells:Regulationof niche, self-renewal anddifferentiation. Arthritis Res Ther 2007;9:204.
28. Lee WC, Shi H, Poon Z et al. Needle in a haystack: Biophysical markers predictive of mesenchymal stromal cell multipotency. Proc Natl Acad Sci USA 2014;111:E4409–E4418.
29. Wu L, Guan G, Hou HW et al. Separation of leukocytes from blood using spiral channel with trapezoid cross-section. Anal Chem 2012; 84:9324–9331.
30. Guan G, Wu L, Bhagat AA et al. Spiral microchannel with rectangular and trapezoidal cross-sections for size based particle separation. Sci Rep 2013;3:1475.
31. Whitfield MJ, Lee WC, Van Vliet KJ. Onset of heterogeneity in culture-expanded bone marrow stromal cells. Stem Cell Res (Amst) 2013;11:1365–1377.
32. Galipeau J. The mesenchymal stromal cells dilemma: Does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy 2013;15:2–8.
33. Chen FM, Zhang M, Wu ZF. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010;31:6279–6308.
34. Park JS, Yang HN, Woo DG et al. The promotion of chondrogenesis, osteogenesis, and adipogenesis of human mesenchymal stem cells by multiple growth factors incorporated into nanosphere-coated microspheres. Biomaterials 2011;32:28–38.
35. Jung S, Panchalingam KM, Wuerth RD et al. Large-scale production of human mesenchymal stem cells for clinical applications. Biotechnol Appl Biochem 2012;59:106–120.
36. Schallmoser K, Rohde E, Reinisch A et al. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 2008;14:185–196.
37. Kean TJ, Lin P, Caplan AI et al. MSCs: Delivery routes and engraftment, cell-targeting strategies, and immune modulation. Stem Cells Int 2013;2013:732742.
38. Kopp HG, Avecilla ST, Hooper AT et al. The bone marrow vascular niche: Home of HSC differentiation and mobilization. Physiology (Bethesda) 2005;20:349–356.
39. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: The first 25 years and beyond. Blood 2013;122:491–498.
40. Kong Y, Chang YJ, Wang YZ et al. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013; 19:1465–1473.